Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 06, 16:00
2891.95
21.8 (0.76%)
VOLUME 27,353
LIVE
NSE
Dec 06, 15:59
2890.80
19.2 (0.67%)
VOLUME 988,519
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Dr Reddys Labs on dip; target Rs 2150-2320: AnandRathi

12.19 pm | 28 Dec 2012 |  Source: Moneycontrol.com

AnandRathi is bullish on Dr Reddys Labs and has recommended to buy the stock on dips for the targets of Rs 2150-2320 in its December 27, 2012 research...

Dr Reddy's launches open offer for OctoPlus shares

10.53 am | 14 Dec 2012 |  Source: Moneycontrol.com

Dr Reddy's Laboratories has launched the recommended public offer to acquire all the outstanding shares of OctoPlus NV at 0.52 euro a share, the pharm...

Emkay bullish on 8 largecaps for long term investment

1.02 pm | 13 Dec 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has come out with its report on investment in 8 largecap stocks. ...

Credit Suisse upgrades Dr Reddy's on US outlook

1.00 pm | 13 Dec 2012 |  Source: Reuters

Credit Suisse upgrades Dr. Reddy's Laboratories to 'outperform' from 'neutral' and raises its target price to Rs 2,150 from Rs 1,900, citing expectati...

Hold Bajaj Auto, Dr Reddy's Labs: Rikesh Parikh 

2.34 pm | 11 Dec 2012 |  Source: CNBC-TV18

Rikesh Parikh, Motilal Oswal Financial Services is of the view that one can hold Bajaj Auto, Dr Reddy’s Laboratories....

Buying opportunity seen in Dr Reddys, says Sukhani 

6.14 pm | 10 Dec 2012 |  Source: CNBC-TV18

Buying opportunity is seen in Dr Reddys at current prices, says Sudarshan Sukhani, s2analytics.com....

Go long in Dr Reddys Lab on dips: Amit Gupta 

10.15 am | 10 Dec 2012 |  Source: CNBC-TV18

Go long in Dr Reddys Laboratories on dips and look for a target of Rs 1,920 and keep stop loss below Rs 1750, says Amit Gupta, ICICI Direct....

Dr Reddy's Lab launches prostate cancer drug in India

6.41 pm | 07 Dec 2012 |  Source: PTI

Drug firm Dr Reddy's Laboratories said it has launched a cancer drug 'Pamorelin LA' in the country under an agreement with Switzerland-based Debiophar...

Buy Dr Reddys Labs; target of Rs 2044: Firstcall Research

12.56 pm | 07 Dec 2012 |  Source: Moneycontrol.com

Firstcall Research is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 2044 in its December 4, 2012 research ...

Dr Reddys Lab appoints Umang Vohra as Executive VP & North America Head

4.20 pm | 27 Nov 2012 |  Source: Moneycontrol.com

Dr Reddys Lab appoints Umang Vohra as Executive VP & North America Head...

India approves policy to cap prices of 348 medicines

9.01 am | 23 Nov 2012 |  Source: Reuters

India approved a new drug pricing policy designed to increase the number of drugs deemed essential that are subject to price caps, two ministers told ...

Buy Dr Reddy's; Divis Lab, Biocon good bets: IIFL Cap 

12.20 pm | 20 Nov 2012 |  Source: CNBC-TV18

Concentrating on the pharma space, Bino Pathiparampil of IIFL Capital told CNBC-TV18 the success of Biocon’s oral insulin product deal would be a po...

Introduce market-based pricing for drugs: Assocham to govt

8.24 pm | 19 Nov 2012 |  Source: PTI

Industry body Assocham today asked the government to introduce a market-based pricing policy for drugs, saying it will help encourage investments in t...

Dr Reddy's announces launch of Sildenafil tablets

3.36 pm | 19 Nov 2012 |  Source: PTI

Pharma major Dr Reddy's Laboratories today announced that it has launched Sildenafil tablets, a bioequivalent generic version of Revatio (Sildenafil) ...

Dr Reddy's announces launch of Sildenafil tablets

3.35 pm | 19 Nov 2012 |  Source: PTI

Pharma major Dr Reddy's Laboratories today announced that it has launched Sildenafil tablets, a bioequivalent generic version of Revatio (Sildenafil) ...

Dr Reddys launches generic Revatio tablets in US

2.13 pm | 19 Nov 2012 |  Source: Moneycontrol.com

Dr Reddys has launched Sildenafil Tablets (20mg), a bioequivalent version of REVATIO (Sildenafil) tablets in the US market on November 16, 2012....

Check out: Prabhudas Lilladher's largecap and midcap picks 

11.23 am | 19 Nov 2012 |  Source: CNBC-TV18

Ajay Bodke of Prabhudas Lilladher says on ground implementation of reforms and the pace and extent of rate cuts, which the RBI could unveil post Janua...

Dr Reddys launches generic Revatio tablets in US; stk up

9.47 am | 19 Nov 2012 |  Source: Moneycontrol.com

Dr Reddys Laboratories has launched generic Revatio tablets in US, reports CNBC-TV18. At 09:45 hrs Dr Reddys Laboratories was quoting at Rs 1,770, up ...

Q2 earnings: 9 stocks that beat estimates; 10 that didn't

12.08 pm | 17 Nov 2012 |  Source: Moneycontrol.com

With the September quarter earnings season just concluded, analysts are now taking stock of the numbers, and the hits and misses....

Dr Reddy's expects to launch open offer for OctoPlus in Dec

5.46 pm | 16 Nov 2012 |  Source: PTI

Drug firm Dr Reddy's Laboratories today said it expects to launch a public offer in December to acquire all outstanding shares of Netherlands-based Oc...

1 2 3 4 5 6 7
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.